Roche's antibody cocktail now available in India, Cipla to market in pan India

On Monday, Drug manufacturer Roche India has announced Roche's Antibody Cocktail's launch in India to treat mild to moderate Covid-19 in patients at high risk, and Cipla will be responsible for the market it in Pan-India. Cipla will distribute the product by leveraging its strong distribution strengths across the country. In an exclusive chat with V Simpson Emmanuel, Managing Director and CEO of Roche Pharma India, says that the drug will be effective on more 12 years old children to all adults with the weight of 40 kgs. Watch out for the video for more information.